Home › Funds › NUANCE INVESTMENTS, LLC › SOLV
NUANCE INVESTMENTS, LLC position in SOLV
SOLVENTUM CORP · Health Care
NUANCE INVESTMENTS, LLC reported holding 271,255 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$23.9M, representing 4.39% of its reported portfolio and ranking #5 among its reported holdings. NUANCE INVESTMENTS, LLC has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NUANCE INVESTMENTS, LLC's SOLV position evolved
NUANCE INVESTMENTS, LLC first disclosed a stake in SOLV in Q2 2024 at 2,190,410 shares (US$115.8M). Across 10 filings, NUANCE INVESTMENTS, LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 271,255 shares valued at US$23.9M — a reduction of -93,275 shares quarter over quarter.. Notable position changes include a 48% trim in Q1 2025 (shares were roughly flat over the following quarter), a 26% increase in Q2 2025 (shares fell 4% over the following quarter), a 46% trim in Q2 2026 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 2.19M | $115.83M | New |
| Q3 2024 | 1.64M | $114.30M | Reduce |
| Q4 2024 | 1.36M | $89.59M | Reduce |
| Q1 2025 | 700.37K | $53.26M | Reduce |
| Q2 2025 | 883.39K | $67.00M | Add |
| Q3 2025 | 696.97K | $50.88M | Reduce |
| Q4 2025 | 642.07K | $50.88M | Reduce |
| Q1 2026 | 671.15K | $43.83M | Add |
| Q2 2026 | 364.53K | $28.12M | Reduce |
| Q3 2026 | 271.25K | $23.91M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SOLV and 13F data
SOLV (SOLVENTUM CORP) is a Health Care company. 41 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SOLV
- Independent Franchise Partners LLP 15.67M sh · $1.38B · Q3 2026
- TRIAN FUND MANAGEMENT, L.P. 8.24M sh · $635.47M · Q2 2026
- DAVIS SELECTED ADVISERS 6.41M sh · $565.42M · Q3 2026
- Diamond Hill Capital Management, LLC (Investment Advisor) 1.58M sh · $139.38M · Q3 2026
- Madison Avenue Partners, LP 1.74M sh · $134.34M · Q2 2026
- EQUITY INVESTMENT CORP 867.55K sh · $76.47M · Q3 2026
- ANCHOR CAPITAL ADVISORS LLC 533.38K sh · $47.02M · Q3 2026
More on NUANCE INVESTMENTS, LLC
FAQ
How long has NUANCE INVESTMENTS, LLC held SOLV?
NUANCE INVESTMENTS, LLC has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is NUANCE INVESTMENTS, LLC's current position in SOLV?
As of Q3 2026, NUANCE INVESTMENTS, LLC holds 271.25K shares of SOLV (SOLVENTUM CORP), valued at $23.91M, representing 4.39% of its reported portfolio and ranking #5.
Has NUANCE INVESTMENTS, LLC been buying or selling SOLV?
In the latest 13F filing (Q3 2026), NUANCE INVESTMENTS, LLC reduced its position in SOLV.
Which other funds hold SOLV?
Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.